Results 241 to 250 of about 100,051 (354)

Hyponatremia and Psychotropic Drugs

, 2019
Mireia Martínez Cortés, Pedro Gurillo Muñoz   +1 more
openaire   +4 more sources

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Psychotropic Drugs in Dermatology. Part 2: Antipsychotics, Sedative-Hypnotics and Anxiolytics in Dermatology.

Indian J Dermatol
Choudhary A, Bose S, Varsha KL, Madke B.
europepmc   +1 more source

Use of prescription opioids and other psychotropic drugs during pregnancy and their impact on the mother and developing child: protocol for a cohort study using linked administrative data from Manitoba and British Columbia, Canada. [PDF]

BMJ Open
Singal D, Dahl L, Brownell M, Dormuth C, Bolton JM, Enns JE, Hanlon-Dearman A, Katz A, Katz LY, Kelly LE, Leong C, McGrail K, Nickel NC, Ruth C, Dahl M, Kim J, Chateau D.   +16 more
europepmc   +1 more source

Influence of chronic treatments with psychotropic drugs and electroconvulsive shock on the induction of aggressive behavior following bilateral olfactory bulbectomy in rats

, 1982
Danny Suwandi, Shigenobu Shibata, Shy Yuh Liou, Shigenori Watanabe, Showa Ueki   +4 more
openalex   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study. [PDF]

J Pharm Policy Pract
Bogowicz P, Mehta A, Choudhary S, Brhlikova P, Roderick P, McGettigan P, Farooqui HH, Sharma AN, Pollock AM.   +8 more
europepmc   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

Keep in mind sex differences when prescribing psychotropic drugs. [PDF]

World J Psychiatry
Mazza M, De Berardis D, Marano G.
europepmc   +1 more source